Magnus Medical

Magnus Medical

Medical Devices, Burlingame, California, 94010, United States, 11-50 Employees

magnusmed.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +14*********

Who is MAGNUS MEDICAL

Magnus Medical is a privately held medical device company driven to transform lives by restoring mental health. The company is a developer of brain stimulation technology for the treatmen...

Read More

map
  • Burlingame, California, 94010, United States Headquarters: Burlingame, California, 94010, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million

industries-icon Industry: Medical Devices

SIC SIC Code: 3949 | NAICS Code: 454210 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from MAGNUS MEDICAL

Magnus Medical Org Chart and Mapping

Employees

Sam Holladay

Senior Embedded Systems Engineer

Natalie Kowta

Executive Creative Director

Tj Ford

Field Clinical Engineer

Marcia Gutierrez

Clinical Operations Manager

Sylwia Felong

Research and Grants Finance Manager

Yann Picard

Senior Software Engineer

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Magnus Medical

Answer: Magnus Medical's headquarters are located at Burlingame, California, 94010, United States

Answer: Magnus Medical's phone number is +14*********

Answer: Magnus Medical's official website is https://magnusmed.com

Answer: Magnus Medical's revenue is $5 Million to $10 Million

Answer: Magnus Medical's SIC: 3949

Answer: Magnus Medical's NAICS: 454210

Answer: Magnus Medical has 11-50 employees

Answer: Magnus Medical is in Medical Devices

Answer: Magnus Medical contact info: Phone number: +14********* Website: https://magnusmed.com

Answer: Magnus Medical is a privately held medical device company driven to transform lives by restoring mental health. The company is a developer of brain stimulation technology for the treatment of neuropsychiatric disorders. Its first product is the SAINTTM Neuromodulation System, granted Breakthrough Device Designation and 510(k) clearance by the U.S. Food & Drug Administration (FDA) in September 2022 for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access